Detalhe da pesquisa
1.
Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD.
Vaccines (Basel)
; 12(1)2023 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38250834
2.
Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine.
Pharmaceutics
; 14(7)2022 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35890352